Clonazepam odt recall

Alert Date: J. Recalled Drug: CLONAZEPAM 0.25 MG ODT. Company: PAR PHARM. Reason: Clonazepam Orally Disintegrating tablets 0.25mg

recalled Clonazepam 0.125mg and 0.25mg Orally Disintegrating tablets (ODT) from a single lot due to a packaging error. Some cartons labeled as

Stay up to date with current recall notices by visiting the FDA website. CLONAZEPAM 0.125 MG ODT. On, Endo Pharma recalled CLONAZEPAM 0.125 MG ODT

Clonazepam ODT, USP 0.125 mg - Blister - Clonazepam ODT, USP 0.125 mg Boxed Warnings, Report Adverse Events, FDA Safety Recalls, Presence in Breast Milk

Alert Date: J. Recalled Drug: CLONAZEPAM 0.25 MG ODT. Company: PAR PHARM. Reason: Clonazepam Orally Disintegrating tablets 0.25mg

The US FDA has published a company announcement advising that Endo USA is recalling one lot of Clonazepam Orally Disintegrating Tablets [ODT]

did not recall if the order changes were communicated to him. The Clonazepam (Klonopin) ODT 1 (one) mg, give one tab by mouth three

On J, Endo USA, Inc. voluntarily recalled a single lot of Clonazepam 0.125 mg and 0.25 mg Orally Disintegrating tablets (ODT)

Endo Expanded recall of clonazepam orally disintegrating tablets (ODT) On J, Endo announced a consumer level recall of one lot of clonazepam 0.25 mg ODT which may also appear as clonazepam 0.125 mg ODT. The recall is expanded to include the 0.125 mg strength. The recall was first announced on J.